The SOS Steering Committee is made up of distinguished peers of the pharmaceutical and science communities, chosen for their expertise in stability research and innovation. We are proud to introduce this year’s seven members.

Jean-René Authelin, Ph.D.

Senior Scientific Advisor for Global CMC Development, Sanofi S.A.

Steven W. Baertschi, Ph.D., FAAPS
President, Baertschi Consulting LLC

Sanjay Konagurthu, Ph.D.
Senior Director, Science and Innovation, Thermo Fisher Scientific

Christian Laue, Ph.D.
Principal Scientist and Laboratory Head in Analytical Development, Merck Healthcare KGaA

Anthony Mazzeo, Ph.D.

Associate Scientific Director of Analytical Strategy and Operations, Bristol Myers Squibb

Garry Scrivens, Ph.D.
Associate Research Fellow, Pfizer (UK)

Kenneth C. Waterman, Ph.D.
President, FreeThink Technologies LLC


Read Their Bios

SOS 2022 Program

The SOS 2022 program is currently in development, and there are a limited number of full-length, featured speaking opportunities available to those who are interested. To be considered, please submit a presentation topic with the speaker’s information to Carolyn Rothfeld.

Stay Up to Date

Visit the SOS website often for news about speakers and other conference details, or let us know if you’re interested in joining our mailing list!